Markus Renschler MD

US·SEC (Form 4)

Cyteir Therapeutics, Inc.

Cumul. flow

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 05 Mar 2024 for Cyteir Therapeutics, Inc., €2,809.

Insider track record

Disclosed buys

Disclosed sells

Signal history

Markus Renschler MD: trading record in brief

All filings by Markus Renschler MD on record concern Cyteir Therapeutics, Inc. In total, 10 filings cover trades dated from 21 December 2022 to 4 March 2024.

The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Most recently, on 5 March 2024, the filings show an option exercise worth €2,809 in Cyteir Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Markus Renschler MD

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Cyteir Therapeutics, Inc. (US)

Declarations10 total

◇

Markus Renschler MD

President and CEOExecutives29 Feb 2024Cyteir Therapeutics, Inc.

3,044 USD0SEC

2,537 shares@ US$1.20Common StockSEC:0001209191-24-004438:1

◇

Markus Renschler MD

President and CEOExecutives4 Mar 2024Cyteir Therapeutics, Inc.

10,654 USD0SEC

6,304 shares@ US$1.69Common StockSEC:0001209191-24-004438:2

◇

Markus Renschler MD

President and CEOExecutives29 Feb 2024Cyteir Therapeutics, Inc.

21,306 USD23SEC

12,607 shares@ US$1.698.6% of flowCommon StockSEC:0001209191-24-004438:0

◇

Markus Renschler MD

President and CEOExecutives20 Nov 2023Cyteir Therapeutics, Inc.

3,043 USD0SEC

2,536 shares@ US$1.20Common StockSEC:0001209191-23-058609:1

◇

Markus Renschler MD

President and CEOExecutives20 Nov 2023Cyteir Therapeutics, Inc.

10,654 USD22SEC

6,304 shares@ US$1.694.3% of flowCommon StockSEC:0001209191-23-058609:0

◇

Markus Renschler MD

President and CEOExecutives20 Nov 2023Cyteir Therapeutics, Inc.

33,480 USD0SEC

27,900 shares@ US$1.20Common StockSEC:0001209191-23-056426:1

◇

Markus Renschler MD

President and CEOExecutives20 Nov 2023Cyteir Therapeutics, Inc.

95,886 USD26SEC

56,737 shares@ US$1.6938.7% of flowCommon StockSEC:0001209191-23-056426:0

◆

Markus Renschler MD

President and CEOExecutives13 Jan 2023Cyteir Therapeutics, Inc.

7,450 USD22SEC

5,000 shares@ US$1.493.0% of flowCommon StockSEC:0001209191-23-007494:0

◇

Markus Renschler MD

President and CEOExecutives21 Dec 2022Cyteir Therapeutics, Inc.

36,524 USD0SEC

30,437 shares@ US$1.20Common StockSEC:0001209191-22-062627:1

◇

Markus Renschler MD

President and CEOExecutives21 Dec 2022Cyteir Therapeutics, Inc.

109,535 USD27SEC

106,345 shares@ US$1.0345.4% of flowCommon StockSEC:0001209191-22-062627:0

10 of 10 declarations

Markus Renschler MD: trading record in brief

All filings by Markus Renschler MD on record concern Cyteir Therapeutics, Inc. In total, 10 filings cover trades dated from 21 December 2022 to 4 March 2024.

Markus Renschler MD

Insider track record

Markus Renschler MD: trading record in brief

Companies and markets linked to Markus Renschler MD

Related entities

Markus Renschler MD

Insider track record

Markus Renschler MD: trading record in brief

Companies and markets linked to Markus Renschler MD

Related entities